Cancer Clinical Trials in San Francisco, California

12 studies are recruiting for cancer in San Francisco, California right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Fatigue and Molecular Mechanisms in Cancer Patients Receiving CCRT

   Cancer-related fatigue (CRF) is a significant problem for cancer patients. This prospective, basic science, observational study will evaluate for changes in CRF associated with molecular characteristics prior to, during, and at the completion of non-investigational, standard-of-care, combined chemo…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of California, San Francisco, San Francisco, California

   Run by

   University of California, San Francisco

   See if you can join NCT06633224 on ClinicalTrials.gov

2. FOG-001 in Locally Advanced or Metastatic Solid Tumors

   The goal of this clinical trial is to determine if FOG-001 is safe and effective in participants with locally advanced or metastatic solid tumors or in participants with familial adenomatous polyposis (FAP).

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, San Francisco, California

   Locations

   33 in total

   Run by

   Parabilis Medicines, Inc.

   See if you can join NCT05919264 on ClinicalTrials.gov

3. Pan Tumor Rollover Study

   Main Objective of this study is to examine long-term safety of nivolumab monotherapy including combinations and other cancer therapies in various tumor types.

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Local Institution, San Francisco, California

   Locations

   399 in total

   Run by

   Bristol-Myers Squibb

   See if you can join NCT03899155 on ClinicalTrials.gov

4. GOLD: Brief Intervention to Reduce Anxiety and Promote Resilience in Families of Youth With Cancer

   The purpose of this study is to examine a psychotherapeutic and psycho-educational intervention offered in virtual settings to caregivers of youth with cancer. Human subjects must be used because they are the object of the intervention.

   Stage

   Not phased

   Ages

   8 to 18

   Site

   Stanford Cancer Institute, San Francisco, California

   Run by

   Stanford University

   See if you can join NCT05415007 on ClinicalTrials.gov

5. Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)

   Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

   Stage

   Phase 2

   Ages

   2 to 25

   Site

   The Unviersity of California, San Francisco (UCSF), San Francisco, California

   Locations

   5 in total

   Run by

   Children's Hospital of Philadelphia

   See if you can join NCT06458036 on ClinicalTrials.gov

6. Childhood Cancer Survivor Study

   The Childhood Cancer Survivor Study (CCSS) will investigate the long-term effects of cancer and its associated therapies. A retrospective cohort study will be conducted through a multi-institutional collaboration, which will involve the identification and active follow-up of a cohort of approximate…

   Stage

   Not phased

   Ages

   Any age

   Site

   University of California-San Francisco, San Francisco, California

   Locations

   31 in total

   Run by

   St. Jude Children's Research Hospital

   See if you can join NCT01120353 on ClinicalTrials.gov

7. Galleri® in the Medicare Population.

   This multi-center comparative prospective cohort study is designed to assess the real world clinical impact, including safety and test performance, of Galleri®, a blood-based multi-cancer early detection (MCED) test. The study will seek enrollment that is representative of the Medicare population.

   Stage

   Not phased

   Ages

   50 and older

   Site

   University of California San Francisco Health System, San Francisco, California

   Locations

   61 in total

   Run by

   GRAIL, Inc.

   See if you can join NCT05673018 on ClinicalTrials.gov

8. Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

   This cluster-randomized comparative effectiveness trial compares a technology-based supportive cancer care (SCC) approach with a redesigned team-based supportive cancer care (SCC) approach.

   Stage

   Not phased

   Ages

   18 and older

   Site

   Zuckerberg San Francisco General, San Francisco, California

   Locations

   17 in total

   Run by

   Stanford University

   See if you can join NCT05297734 on ClinicalTrials.gov

9. Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors

   This is a first-in-human (FIH), open label Phase 1/1b / Phase 2 study in patients with advanced metastatic solid tumors refractory to standard treatment. Phase 1 will identify potential optimal biologically relevant doses (OBRD) and the maximum tolerated dose (MTD) of MBRC-101 at one 1 or more dosi…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California

   Locations

   17 in total

   Run by

   MBrace Therapeutics

   See if you can join NCT06014658 on ClinicalTrials.gov

10. Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

    Papillary thyroid cancer (PTC) is the most common form of differentiated thyroid cancer (DTC). The traditional first line treatment for patients with advanced DTC after surgical resection is radioactive iodine (RAI) therapy. However, less than a quarter of patients with lung metastases will achieve…

    Stage

    Phase 2

    Ages

    2 to 99

    Site

    University of California, San Francisco, San Francisco, California

    Locations

    5 in total

    Run by

    Children's Hospital of Philadelphia

    See if you can join NCT05783323 on ClinicalTrials.gov

11. ChangeGradients: Promoting Adolescent Health Behavior Change

    As most adolescents visit a healthcare provider once a year, health behavior change interventions linked to clinic-based health information technologies hold significant promise for improving healthcare quality and subsequent behavioral health outcomes for adolescents (Baird, 2014, Harris, 2017). R…

    Stage

    Not phased

    Ages

    15 to 17

    Site

    University of California San Francisco Adolescent and Young Adult Medicine Clinic, San Francisco, California

    Run by

    University of California, San Francisco

    See if you can join NCT04110756 on ClinicalTrials.gov

12. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage

    Not phased

    Ages

    Any age

    Site

    Massive Bio SYNERGY-AI site, San Francisco, California

    Locations

    68 in total

    Run by

    Massive Bio, Inc.

    See if you can join NCT03452774 on ClinicalTrials.gov